Ann: NASDAQ Progression - Medlab Clears SEC Comments, page-8

I can't argue with that mate - I really don't know why MDC is continually getting sold down, or why other companies with far more debt and far less blue sky aren't. I don't think management like it any more than the rest of us shareholders, but I'm sure they're not involved.

There's definitely a buy/sell liquidity issue; just no buyers to be seen and as a result a few thousand dollars of shares each day dumps the market cap. At some point you'd expect buyers to see value and step in to soak up the small sales easily, but it's a pretty volatile market out there right now, and Medlab needs some big news to get back on investors' radar.

It's why I want this Nasdaq listing to come off : ~$20m cash in the bank and some global attention would go a long way for Medlab, and arbitrage from an overseas exchange would potentially make it impossible to mess with the SP on the ASX like I sometimes suspect happens here (going by course of sales).